MedDataX Logo

Milk as Treatment for Hypoglycemia

NCT ID: NCT00643110

Last Updated: 2015-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Test hypothesis that milk can raise blood sugars as well as orange juice or glucose tablets without raising blood sugars too much the way that orange juice or glucose tablets sometimes do.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant

NCT04030312

Neonatal Hypoglycemia
COMPLETED NA

Naltrexone and Hypoglycemia in Type 1 Diabetes

NCT01053078

Type 1 Diabetes Hypoglycemia Unawareness
COMPLETED PHASE1/PHASE2

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

NCT02523222

Hypoglycemia Infant, Small for Gestational Age Premature Birth of Newborn +4 more
COMPLETED PHASE2/PHASE3

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

NCT01462227

Hypoglycemia
COMPLETED NA

Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans

NCT04392843

Hypoglycemia
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will wear a continuous glucose monitor prior to test to determine normal glucose levels. The morning of the test an IV will be inserted into the subject and insulin and saline drips will be started. Blood glucose levels will be checked every 10 minutes until the subject becomes hypoglycemic. IVs will be stopped at that time and subject will be given skim milk, orange juice or glucose tablets at that time. Blood will be drawn every 15 minutes until blood sugars stabilize. Blood draws will be analyzed to determine glucose, insulin, epinephrine, norepinephrine, glucagon, cortisol, growth hormone and GLP-1 levels. Procedure will be repeated two more times using other glucose methods (skim milk, orange juice or glucose tablets).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

D50 glucose

D50 glucose would be administered, if necessary.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 1 Diabetes
* Able to be consented
* Able to wear continuous glucose monitor
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Creighton University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Creighton University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Creighton Diabetes Center

Omaha, Nebraska, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Dairy Council - Rendell 01

Identifier Type: -

Identifier Source: secondary_id

Rendell 01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia
NCT03286816 COMPLETED NA
The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia
NCT02308293 COMPLETED NA
Liver Glycogen and Hypoglycemia in Humans
NCT03241706 ACTIVE_NOT_RECRUITING PHASE1
The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia
NCT03730909 UNKNOWN NA
The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia
NCT00600730 WITHDRAWN NA
Effect of C-peptide on Hypoglycemic Counterregulation
NCT06470295 RECRUITING EARLY_PHASE1
Primary Care Clinicians' Responses to a Hypoglycemia Risk Calculator for Diabetes Mellitus in Ambulatory Care
NCT04177147 COMPLETED NA
Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans
NCT01660009 TERMINATED NA
Naloxone, Hypoglycemia and Exercise
NCT03149770 COMPLETED PHASE2
Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
NCT04085978 TERMINATED
Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes
NCT02866435 COMPLETED EARLY_PHASE1
The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow
NCT02146404 COMPLETED NA
Oral Anti Diabetic Agents in the Hospital
NCT04416269 RECRUITING PHASE4
Treatment of Hypoglycemia in Type 1 Diabetes
NCT03489967 COMPLETED NA
Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children
NCT00487006 COMPLETED NA
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
NCT03520569 COMPLETED EARLY_PHASE1
Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
NCT04876079 COMPLETED NA
Disorders of Systemic Glucose Balance
NCT00006508 COMPLETED NA
Study of a Primary Care Hypoglycemia Prevention Program
NCT06353217 ACTIVE_NOT_RECRUITING NA
Diagnosing and Treating Low Blood Sugar Levels
NCT00001276 RECRUITING
Hypoglycemia: Physician and Patient Perspectives
NCT01176656 COMPLETED
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation
NCT00779701 COMPLETED PHASE4
Mechanisms of Hypoglycemia Associated Autonomic Failure
NCT00678145 UNKNOWN PHASE2
Hypoglycemia in Hospitalized Patients
NCT02228642 COMPLETED
Glucose Response to a Formula for Patients at Risk of Hypoglycaemia
NCT05676385 COMPLETED NA